undefined | Better HN

0 pointsdanso10y ago0 comments

Not being forthright about the scope of their technological progress and innovation, which is ostensibly the basis of its $9 billion valuation.

0 comments

codezero10y ago

Who must they be forthright to? I mean, I agree, obviously, but if they aren't forthright and their investors are still paying, the investors suffer, how is the consumer suffering here?

Are they promising a product that they aren't delivering?

Sorry, I know I'm being difficult here, I would really love to chat with someone who is very invested either for or against, or both, this approach, so that I can understand better.

Seriously, if you, or you know anyone who has time to chat about this, send me an email. I don't intend to be as contrarian as I know I appear to be (and probably am being) here.

I really care, and just for purely reasons of curiosity. Anyways, ping me if we can chat.

anon841810y ago

Well they should at least be forthright with customers/patients. There are lots of anecdotal blog posts (one by former Apple vp of engineering) about the accuracy of their tests for example. Remember this is about people's health, so you can imagine the sensitivity here compared to your usual consumer type of startup.

In regards to the rest of your comment (as well as your other posts littering this thread), your not being difficult as so much as lazy :P

A quick Google search and 15 mins of reading will catch you up to speed about Theranos and all the (negative) attention they are currently receiving in the press. Start with the series of recent WSJ articles about Theranos.

j / k navigate · click thread line to collapse